Overview
Objective Biotechnology develops fully automated microinjection systems for large-scale genetic manipulation of cells and organisms, including the Autoinjector for precise embryo injections in gene editing and transgenesis. The technology uses machine learning and computer vision to enhance speed, consistency, and accessibility in genetic research across insect and vertebrate models. Based in Minneapolis, MN, the company supports researchers in streamlining complex protocols previously requiring extensive manual training.
Frequently asked questions
- What capabilities does Objective Biotechnology's Autoinjector provide?
- The Autoinjector automates microinjection for genetic engineering and gene editing in model organisms, enabling high-speed, precise embryo injections using machine learning and computer vision, with success in insect and vertebrate models.
- What regulatory or compliance features are offered?
- Objective Biotechnology's systems support consistent, high-quality results in research protocols, reducing training time from months to weeks, though specific regulatory certifications are not detailed in available information.
- Where is Objective Biotechnology located and what geographies do they serve?
- The company is based in Minneapolis, MN, USA, and offers products for global purchase directly from their website, with early access sites demonstrating use in 2024.